PCSK9 inhibitor access remains a significant barrier, leaving patients at risk for heart attacks and strokes
A new study published in Circulation: Cardiovascular Quality and Outcomes from the Family Heart Foundation—a patient-centered research and advocacy nonprofit organization dedicated to improving the lives of families impacted ...
Feb 20, 2024
0
2